Subscribe To
: kala pharmaceuticals stock rockets nearly 300% after fda oks ind application for pced treatment
Shares of Kala pharmaceuticals Inc. KALA quadrupled in very volatile trading Wednesday, after the bio...
December 28, 2022, 5:44 pm
Rhythm pharma: an incremental approach works well for setmelanotide
Rhythm pharmaceuticals is planning to get approvals for setmelanotide in an incremental fashion. Each n...
December 28, 2022, 1:53 pm
Kala pharmaceuticals stock surges on fda update
Kala pharmaceuticals Inc (NASDAQ:KALA) is bucking the broader-market trend this afternoon, up 283.2% l...
December 28, 2022, 1:18 pm
Why is kala pharmaceuticals (kala) stock soaring 240%?
Amid another soft performance for the benchmark equities index, rare-eye disease specialist Kala pharmaceutica...
December 28, 2022, 1:14 pm
Nexcella, inc announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car t-cell meeting
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...
December 28, 2022, 1:05 pm
Zymeworks (zyme) stock up 29% in three months: here's why
Zymeworks (ZYME) recently entered a collaboration with Jazz pharmaceuticals (JAZZ) for its lead pipelin...
December 28, 2022, 12:21 pm
Kala pharmaceuticals (kala) up as fda accepts ind for kpi-012
The FDA accepts Kala pharmaceuticals' (KALA) investigational new drug application for pipeline candidat...
December 28, 2022, 12:21 pm
Kala pharmaceuticals stock rockets after fda accepts ind application for pced treatment
Shares of Kala pharmaceuticals Inc. KALA, +1.03% shot up 45.7% in premarket trading Wednesday, after th...
December 28, 2022, 6:48 am
Teva pharmaceutical: 2023 could finally be the stock's breakout year
Shares look to have been undergoing a bottoming pattern for well over three years now. Although near-term EPS revisions have been faltering, Teva's re...
December 28, 2022, 6:27 am
Kala pharmaceuticals announces fda acceptance of ind application for kpi-012 for the treatment of pced
— On-track to initiate Phase 2b trial in 1Q 2023; Topline data expected in 1Q 2024 — — Received remaining $25 million investment under previousl...
December 27, 2022, 9:01 pm
Springworks therapeutics completes submission of new drug application to the fda for nirogacestat for the treatment of adults with desmoid tumors
STAMFORD, Conn., Dec. 27, 2022 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage bio...
December 27, 2022, 11:30 am
Algernon pharma inks equity distribution agreement to raise aggregate gross proceeds of up to $5.0m
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said it has entered into an equity distribution ag...
December 27, 2022, 7:36 am
Is vertex pharmaceuticals a buy?
There's more growth ahead for this biotech giant....
December 27, 2022, 6:15 am
Dow jones newswires: chinese drug makers’ shares plunge as pfizer’s paxlovid gains market share
Shares of Chinese pharmaceutical companies plunged Tuesday morning on Chinese bourses, continuing a sli...
December 27, 2022, 3:46 am
Madrigal pharmaceuticals setting the standard
Madrigal's lead drug candidate was already expected to be successful in its pivotal trial. FDA approval would then be earned by a positive on one of t...
December 26, 2022, 12:36 pm
Are medical stocks lagging aveo pharmaceuticals (aveo) this year?
Here is how AVEO pharmaceuticals (AVEO) and Merit Medical (MMSI) have performed compared to their secto...
December 26, 2022, 11:17 am
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in spectrum pharmaceuticals, inc. of class acton lawsuit and upcoming deadline – sppi
NEW YORK, Dec. 25, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Spectrum ...
December 25, 2022, 1:08 pm
Rosen, national investor counsel, encourages eiger biopharmaceuticals, inc. investors with losses to secure counsel before important deadline in securities class action – eigr
NEW YORK, Dec. 24, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger Bio...
December 24, 2022, 4:43 pm
Rosen, skilled investor counsel, encourages spectrum pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action – sppi
NEW YORK, Dec. 23, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum ...
December 23, 2022, 10:28 pm
Terns announces closing of public offering of shares of common stock, including full exercise of underwriters’ option to purchase additional shares
FOSTER CITY, Calif., Dec. 23, 2022 (GLOBE NEWSWIRE) — Terns pharmaceuticals, Inc. (“Terns” or the...
December 23, 2022, 9:05 pm